PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.

Recruiting now

Conditions studied: Small Cell Lung Carcinoma

In brief

There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society/Cancer Aid/AWMF

Key facts

Study ID

NCT06247163

Run by

University Hospital, Essen

People needed

30

Starts

2024-02-22

Expected to finish

2029-06-22

Last updated by the study team

2024-09-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histopathologic confirmation
• Limited disease

You may not qualify if…

• Other histology than small cell lung cancer
• Further tumor diagnosis
• ECOG 3 or worse
• Extensive disease
• stage IV

Where it is running

• University Hospital Essen — Essen, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.